Results

Total Results: 2,015 records

Showing results for "type".

381. The Effect of Protein Intake on Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-protocol-amendment.pdf
     November 29, 2023 - , and dietary supplements No specification on the amount of protein intake (e.g., only the type … size, age, gender/sex, race/ethnicity, socioeconomic status, physical activity level, health status, type … DerSimonian-Laird approach which may result in overly narrow confidence intervals that can lead to Type … The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle … KQ1-3 Exclusion criteria: No specification on the amount of protein intake (e.g., only the type

382. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
     March 14, 2012 - Using this definition, the cumulative incidence of gastroparesis is 4.8 percent in people with type … 1 diabetes, 1.0 percent in people with type 2 diabetes, and 0.1 percent in people without diabetes but … For radiopaque markers, we would collect data on the type of radiopaque markers used, the timing of … For colon scintigraphy, we would collect data on type of labeled marker used, type of protocol used, … of the following outcomes: ○ Harms, such as capsule retention, radiation exposure, and mortality Type

383. Health Information Exchange (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange_executive.pdf
     December 01, 2015 - Summary of evidence Topic Number and Type of Included Studies Main Findings Primary Limitations … incomplete description of the functionality and architecture of the systems, making comparison by type … The evidence was insufficient to compare usability by type of HIE function (query-based, or pull, vs … . directed, or push, exchange) or by type of architecture (centralized or not). … The one type of external factor cited as a facilitator was policy in the form of Federal and State

384. The Performance of Fusion Procedures for Degenerative Disease of teh Lumbar Spine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-protocol.pdf
     June 20, 2024 - degenerative, traumatic, and pathologic.2 Types I and II commonly apply to children and adolescents, and type … //effectivehealthcare.ahrq.gov/ 5 medical comorbidities, baseline pain severity, presence and type … For KQ 4, we will also abstract information regarding the type(s) of IONM used, signal thresholds and … For KQ 5 and KQ 6, we will capture additional details regarding patient presentation (e.g., type of … Prevalence of spine degeneration diagnosis by type, age, gender, and obesity using Medicare data.

385. DEcIDE 34 - Developing a Registry of Patient Registries: Options for the Agency for Healthcare Research and Quality (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries-development_research_0.pdf
     February 01, 2012 - longitudinal picture of disease and to obtain additional outcomes (e.g., longer term or a different type … The registry has search capabilities that allow for searching by type of cancer, stage or subtype, type … By study location and topic, but advanced search options are also available (study type, sponsor, … (primary and partner registries each have their own criteria) By type of cancer, stage or … subtype, trial type, location, type of treatment, drug name, and trial phase Searching is available

386. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
     January 01, 2007 - , while agreement within a broad diagnostic category in another 16% (i.e., same body system and/or type … Ref Type: Report 2. Strom, B. L., Carson, J. L., Schinnar, R., Snyder, E. S. & Shaw, M. … Ref Type: Electronic Citation 5. Saliba, W. I. & Natale, A. Ventricular tachycardia syndromes.

387. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
     January 01, 2005 - , while agreement within a broad diagnostic category in another 16% (i.e., same body system and/or type … Ref Type: Report 2. Strom, B. L., Carson, J. L., Schinnar, R., Snyder, E. S. & Shaw, M. … Ref Type: Electronic Citation 5. Saliba, W. I. & Natale, A. Ventricular tachycardia syndromes.

388. Long COVID Models of Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-protocol.pdf
     February 18, 2023 - interventions used and specifics of pharmacological and nonpharmacological treatments, provider type … visits • Process for coordinating care • Methods of follow-up • Source and duration of funding • Type … follow-up) Setting Clinical setting (e.g., primary care, specialty clinic, or standalone clinic; type … definition used for long COVID, insurance status), availability of interventions and services offered, and type

389. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
     September 08, 2011 - systemic infection including, but not limited to, the following: o Sepsis Interventions: Therapy (type … laboratory findings (e.g., leukocytosis, C-reactive protein, bacteremia) Comparators: Therapy (type … Diversity: o Patient characteristics, including  Age  Sex  Race/ethnicity  Disease and type … Comparators Therapy (type, duration) guided by clinical signs/symptoms (e.g., fever, pain), and … Therapy (type, duration) based on clinical signs/symptoms (e.g., fever, pain), and other laboratory

390. EPC Methods: An Exploration of Methods and Context for the Production of Rapid Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
     February 01, 2015 - Most restricted the type of studies included; for example, one used existing reviews if possible, and … ) or synthesis, they are on average the fastest type of product to produce. … All provided conclusions, although some added a number of caveats. 14 In summary, this type of … This type of product was more likely to describe clinicians among end-users. … One type relied on existing SRs. 1-2 weeks Two reports were conducted in 1 to 2 weeks.

391. medication-assisted-treatment-protocol-160224 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
     February 24, 2016 - of interventions used (specifics of pharmacological and nonpharmacological treatments), provider type … interventions  used    (specifics  of  pharmacological  and  nonpharmacological   treatments),  provider  type

392. Mixed MethodsReview -Integrating Palliative Care with Chronic Disease Management in Ambulatory Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
     November 21, 2019 - services, including palliative care) Adverse effects  Medication side effects  Dropouts Type … process evaluation studies Criteria Inclusion Exclusion Comparison No comparison group needed Type … Synthesis Methods Our mixed methods review, having completed separate searches for each type of … Hospice care is a type of palliative care but is not included in this review as it is not delivered in … non- palliative care specialists, such as by primary care clinicians.28 Process evaluation (also type

393. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting-future_research.pdf
     January 01, 2014 - Developing PICOD for Each Gap Based on an a priori categorization of stakeholders according to type … indication for stenting, what is the impact on stenting parameters (e.g., which lesion to stent, type … 4 4.11 5 What is the impact of baseline characteristics (e.g., sex, age, co- morbidities, type of … What factors (e.g., patient/physician characteristics, availability of prior noninvasive testing, type … 4 3.78 6 What is the impact of baseline characteristics (e.g., sex, age, co- morbidities, type of

394. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0002_03-04-2008.pdf
     January 01, 2008 - Population(s): Adults with Type 2 diabetes mellitus admitted to the hospital for non diabetes-related

395. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
     June 01, 2012 - groups Lumping subgroups that are fundamentally different can cause a false finding of a difference (type … splitting subgroups without evidence of different effects) can lead to false-positive (also known as type … 1 error) or false-negative (also known as type 2 error) results. … Spectrum effect The severity or type of disease may affect test accuracy. … The underlying prevalence of undiagnosed type 2 diabetes in pregnancy is increased.

396. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
     June 01, 2012 - groups Lumping subgroups that are fundamentally different can cause a false finding of a difference (type … splitting subgroups without evidence of different effects) can lead to false-positive (also known as type … 1 error) or false-negative (also known as type 2 error) results. … Spectrum effect The severity or type of disease may affect test accuracy. … The underlying prevalence of undiagnosed type 2 diabetes in pregnancy is increased.

397. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ear-infection_research-protocol.pdf
     August 07, 2012 - primary diagnostic method.1 Other factors that help confirm the diagnosis include a flat tympanogram (Type … In KQ 5, we have clarified that location of the treatment provider is more accurately described as “type … (e.g., watchful waiting vs. early treatment), or surgical procedures and techniques (e.g., one type … early treatment), or surgical procedures and techniques (e.g., one type of tympanostomy tube or … (e.g., one type of early treatment), or tympanostomy tube or surgical procedures procedure vs. another

398. Ch 3-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
     September 21, 2012 - If we make a Bonferroni correction for multiple testing in order to maintain the correct Type-I error … probability, we would be further increasing the Type-II error probability, which increases the likelihood … The essential elements of this type of analysis are: clear definition and prespecification of subgroups … The essential elements of this type of analysis are: clear definition and prespecification of subgroups … analytic strategy Prespecified in complete detail Prespecified Not prespecified Control of familywise type

399. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - The rate and type of adverse events did not differ between treatment groups in these studies. … in the ascertainment and reporting of adverse events preclude valid comparisons of the rate and type … The rate and type of adverse events were generally similar between intervention and placebo groups, … The rate and type of adverse events did not differ between treatment groups in these studies. … The rate and type of adverse events were generally similar between intervention and placebo groups

400. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - The rate and type of adverse events did not differ between treatment groups in these studies. … in the ascertainment and reporting of adverse events preclude valid comparisons of the rate and type … The rate and type of adverse events were generally similar between intervention and placebo groups, … The rate and type of adverse events did not differ between treatment groups in these studies. … The rate and type of adverse events were generally similar between intervention and placebo groups